Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

Explainable machine learning for predicting in-hospital mortality in acute heart failure: a prospective single-center cohort study from Vietnam

  1. 1Department of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City
  2. 2Department of Cardiology, Cho Ray Hospital
  3. 3Department of Cardiology, Nhan Dan Gia Dinh Hospital

Abstract

Background: Accurate risk stratification is essential in acute heart failure (AHF), which carries substantial in-hospital mortality. The Get With The Guidelines–Heart Failure (GWTG-HF) score is widely used, but its performance may vary across populations, and prospective data from Southeast Asia are scarce. We developed and internally validated explainable machine-learning (ML) models for in-hospital mortality in a Vietnamese AHF cohort and compared them with the GWTG-HF score.

Methods: We prospectively enrolled 572 consecutive patients admitted with AHF (October 2024–June 2025). Missing data were imputed with a random forest–based algorithm, and class imbalance handled with SMOTE within training folds. Six algorithms (logistic regression, elastic net, random forest, XGBoost, LightGBM, CatBoost) were trained with stratified cross-validation, with optimism correction, and evaluated on an independent 25% test set. We assessed discrimination (ROC-AUC, PR-AUC), calibration (calibration slope/intercept, Brier and scaled Brier scores), classification, and clinical utility (decision-curve analysis); thresholds were derived from training data only. Pairwise AUC comparisons used the DeLong test, and interpretation used SHAP. Reporting followed TRIPOD + AI.

Results: Fifty-three patients (9.3%) died in hospital. Random forest had the highest discrimination (AUC 0.846, 95% CI 0.757–0.922), followed by the GWTG-HF score (0.817), logistic regression (0.795), elastic net (0.794), CatBoost (0.786), XGBoost (0.763), and LightGBM (0.694). No ML model significantly outperformed the GWTG-HF score (all DeLong p > 0.05), a comparison limited by only 13 test-set events. Although CatBoost had the numerically lowest Brier score (0.085), scaled Brier scores were low for all models and calibration intercepts were uniformly negative, indicating over-estimation of risk from aggressive imbalance correction; predicted probabilities therefore require recalibration. SHAP identified respiratory failure, NT-proBNP, high-sensitivity troponin I (risk-increasing) and an ADHF phenotype and left ventricular dilation (associated with lower predicted risk) as the most influential features.

Conclusions: Explainable ML, led by random forest, achieved good discrimination but did not significantly outperform the GWTG-HF score, most plausibly reflecting limited statistical power rather than true equivalence. With miscalibrated probabilities requiring recalibration, explainable ML is best viewed as a complementary risk-ranking tool; external, multicenter, and temporal validation are required before clinical use.

Related

  1. Explainable machine learning and deep learning models for predicting in-hospital mortality in burn patients
    Reza Zarei, Maral Taghizadeh Shalmaei, Masiha Mobayen +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  2. A machine learning-driven and explainable prediction model for in-hospital mortality in patients with diabetes mellitus and congestive heart failure: integrating XGBoost and SHAP approaches.
    Jingru Hu, Shiqiong Su, Dongdong Liu
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  3. Development and validation of an interpretable machine learning model for predicting in-hospital mortality among critically ill patients with liver cirrhosis
    Fengjie Guo, Shijie Zhong, Yang Tan +6
    Scientific ReportsPeer-reviewedCC BYFull text1 citedGeneral medicineDOAJ
  4. Mortality prediction in patients with acute myocardial infarction and prior ischemic stroke: a prospective cohort study with explainable machine learning and SHAP analysis
    Congcong Han, Abudureheman Muladili, Ning Song +5
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  5. Development and temporal validation of an explainable machine learning model for predicting in-hospital diabetic foot ulcer in patients with type 2 diabetes using inflammatory–nutritional composite indices
    Xue Wang, Chao Li, Yanan Tuo +4
    Frontiers in MedicinePeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
BibTeX
@article{hoang2026explainable,
  title = {{Explainable machine learning for predicting in-hospital mortality in acute heart failure: a prospective single-center cohort study from Vietnam}},
  author = {Sy Van Hoang and Kha Minh Nguyen and Tai Nhat Nguyen and Huy Nhat Do},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1927124},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1927124/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Explainable machine learning for predicting in-hospital mortality in acute heart failure: a prospective single-center cohort study from Vietnam
AU  - Sy Van Hoang
AU  - Kha Minh Nguyen
AU  - Tai Nhat Nguyen
AU  - Huy Nhat Do
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1927124
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1927124/full
AB  - Background: Accurate risk stratification is essential in acute heart failure (AHF), which carries substantial in-hospital mortality. The Get With The Guidelines–Heart Failure (GWTG-HF) score is widely used, but its performance may vary across populations, and prospective data from Southeast Asia are scarce. We developed and internally validated explainable machine-learning (ML) models for in-hospital mortality in a Vietnamese AHF cohort and compared them with the GWTG-HF score.  Methods: We prospectively enrolled 572 consecutive patients admitted with AHF (October 2024–June 2025). Missing data were imputed with a random forest–based algorithm, and class imbalance handled with SMOTE within training folds. Six algorithms (logistic regression, elastic net, random forest, XGBoost, LightGBM, CatBoost) were trained with stratified cross-validation, with optimism correction, and evaluated on an independent 25% test set. We assessed discrimination (ROC-AUC, PR-AUC), calibration (calibration slope/intercept, Brier and scaled Brier scores), classification, and clinical utility (decision-curve analysis); thresholds were derived from training data only. Pairwise AUC comparisons used the DeLong test, and interpretation used SHAP. Reporting followed TRIPOD + AI.  Results: Fifty-three patients (9.3%) died in hospital. Random forest had the highest discrimination (AUC 0.846, 95% CI 0.757–0.922), followed by the GWTG-HF score (0.817), logistic regression (0.795), elastic net (0.794), CatBoost (0.786), XGBoost (0.763), and LightGBM (0.694). No ML model significantly outperformed the GWTG-HF score (all DeLong p > 0.05), a comparison limited by only 13 test-set events. Although CatBoost had the numerically lowest Brier score (0.085), scaled Brier scores were low for all models and calibration intercepts were uniformly negative, indicating over-estimation of risk from aggressive imbalance correction; predicted probabilities therefore require recalibration. SHAP identified respiratory failure, NT-proBNP, high-sensitivity troponin I (risk-increasing) and an ADHF phenotype and left ventricular dilation (associated with lower predicted risk) as the most influential features.  Conclusions: Explainable ML, led by random forest, achieved good discrimination but did not significantly outperform the GWTG-HF score, most plausibly reflecting limited statistical power rather than true equivalence. With miscalibrated probabilities requiring recalibration, explainable ML is best viewed as a complementary risk-ranking tool; external, multicenter, and temporal validation are required before clinical use.
SN  - 2297-055X
ER  -